Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuuichi Arakawa
Yuuichi Arakawa
Takeda Pharmaceutical Company
Reuptake inhibitor
Antidepressant
Monoamine neurotransmitter
Biochemistry
Chemistry
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models.
2021
Science Advances
Rina Baba
Satoru Matsuda
Yuuichi Arakawa
Ryuji Yamada
Noriko Suzuki
Tatsuya Ando
Hideyuki Oki
Shigeru Igaki
Masaki Daini
Yasushi Hattori
Matsumoto Shigemitsu
Mitsuhiro Ito
Atsushi Nakatani
Haruhide Kimura
Show All
Source
Cite
Save
Citations (2)
Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles
2019
PLOS ONE
Yuuichi Arakawa
Kazumasa Yokoyama
Shinya Tasaki
Junichi Kato
Kosuke Nakashima
Michiyasu Takeyama
Atsushi Nakatani
Motohisa Suzuki
Show All
Source
Cite
Save
Citations (10)
Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.
2014
Bioorganic & Medicinal Chemistry Letters
Eiji Honda
Yuji Ishichi
Eiji Kimura
Masato Yoshikawa
Naoyuki Kanzaki
Hideyuki Nakagawa
Yasuko Terao
Atsuko Suzuki
Takayuki Kawai
Yuuichi Arakawa
Hiroyuki Ohta
Jun Terauchi
Show All
Source
Cite
Save
Citations (3)
Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.
2013
Bioorganic & Medicinal Chemistry
Yuji Ishichi
Eiji Kimura
Eiji Honda
Masato Yoshikawa
Takashi Nakahata
Yasuko Terao
Atsuko Suzuki
Takayuki Kawai
Yuuichi Arakawa
Hiroyuki Ohta
Naoyuki Kanzaki
Hideyuki Nakagawa
Jun Terauchi
Show All
Source
Cite
Save
Citations (9)
1